Skip to main content
Have a personal or library account? Click to login
The Prevalence and Epidemiological Features of Ischaemic Heart Disease in Sri Lanka Cover

The Prevalence and Epidemiological Features of Ischaemic Heart Disease in Sri Lanka

Open Access
|Jun 2024

References

  1. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Current Problems in Cardiology. 2010; 35(2): 72115. DOI: 10.1016/j.cpcardiol.2009.10.002
  2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. Journal of the American College of Cardiology. 2020; 76(25): 29823021. DOI: 10.1016/j.jacc.2020.11.021
  3. Peiris D, Ghosh A, Manne-Goehler J, Jaacks LM, Theilmann M, Marcus ME, et al. Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data. PLoS Medicine. 2021; 18(3): e1003485. DOI: 10.1371/journal.pmed.1003485
  4. Global Burden of Disease Study 2019 (GBD 2019) Results [Internet]. Institute for Health Metrics and Evaluation (IHME). 2020 [cited 29 April 2021]. Available from: http://ghdx.healthdata.org/gbd-results-tool.
  5. Rajapaksa L, De Silva P, Abeykoon A, Somatunga L, Sathasivam S, Perera S. Sri Lanka Health System In Review. New Delhi: World Health Organization Regional Office for South-East Asia; 2021.
  6. Rannan-Eliya RP, Wijemanne N, Liyanage IK, Jayanthan J, Dalpatadu S, Amarasinghe S, et al. The quality of outpatient primary care in public and private sectors in Sri Lanka–how well do patient perceptions match reality and what are the implications? Health Policy and Planning. 2015; 30 Suppl 1: 5974. DOI: 10.1093/heapol/czu115
  7. Mendis S, Ekanayake EM. Prevalence of coronary heart disease and cardiovascular risk factors in middle aged males in a defined population in central Sri Lanka. International Journal of Cardiolology. 1994; 46(2): 13542. DOI: 10.1016/0167-5273(94)90034-5
  8. Katulanda P, Liyanage IK, Caldera R, Constantine GR, Sheriff RDM. Prevalence of ischaemic heart disease and its risk factors in Sri Lanka (abstract only). Ceylon Medical Journal. 2010; 55.
  9. Hemingway H, Langenberg C, Damant J, Frost C, Pyorala K, Barrett-Connor E. Prevalence of angina in women versus men: A systematic review and meta-analysis of international variations across 31 countries. Circulation. 2008; 117(12): 152636. DOI: 10.1161/CIRCULATIONAHA.107.720953
  10. Mohideen R. Prevalence of angina in a Sri Lankan population (2003) (Personal communication). In: Wijemunige N, (ed.) 2021.
  11. Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015; 101(15): 11829. DOI: 10.1136/heartjnl-2015-307516
  12. Aggarwal R, Chiu N, Pankayatselvan V, Shen C, Yeh R. Prevalence of angina and use of medical therapy among US adults: A nationally representative estimate. American Heart Journal. 2020; 228: 446. DOI: 10.1016/j.ahj.2020.05.016
  13. Graff-Iversen S, Wilsgaard T, Mathiesen EB, Njolstad I, Lochen ML. Long-term cardiovascular consequences of Rose angina at age 20–54 years: 29-years’ follow-up of the Tromso Study. Journal of Epidemiology and Community Health. 2014; 68(8): 7549. DOI: 10.1136/jech-2013-203642
  14. Australian Institute of Health and Welfare. Coronary Heart Disease. Canberra: AIHW; 2020.
  15. Rannan-Eliya RP, Wijemunige N, Perera P, Kapuge Y, Gunawardana N, Sigera C, et al. Prevalence and associations of hypertension in Sri Lankan adults: Estimates from the SLHAS 2018–19 survey using JNC7 and ACC/AHA 2017 guidelines. Global Heart. 2022; 17(1): 50. DOI: 10.5334/gh.1135
  16. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. British Journal of Preventative and Social Medicine. 1977; 31(1): 428. DOI: 10.1136/jech.31.1.42
  17. Lawlor DA, Adamson J, Ebrahim S. Performance of the WHO Rose angina questionnaire in post-menopausal women: Are all of the questions necessary? Journal of Epidemiology and Community Health. 2003; 57(7): 53841. DOI: 10.1136/jech.57.7.538
  18. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data–or tears: An application to educational enrollments in states of India. Demography. 2001; 38(1): 11532. DOI: 10.1353/dem.2001.0003
  19. Rannan-Eliya RP, Wijemunige N, Perera P, Kapuge Y, Gunawardana N, Sigera C, et al. Prevalence of diabetes and pre-diabetes in Sri Lanka: A new global hotspot-estimates from the Sri Lanka Health and Ageing Survey 2018/2019. BMJ Open Diabetes Research & Care. 2023; 11(1). DOI: 10.1136/bmjdrc-2022-003160
  20. StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021.
  21. Bodegard J, Erikssen G, Bjornholt JV, Thelle D, Erikssen J. Possible angina detected by the WHO angina questionnaire in apparently healthy men with a normal exercise ECG: Coronary heart disease or not? A 26-year follow-up study. Heart. 2004; 90(6): 62732. DOI: 10.1136/hrt.2003.012542
  22. Graff-Iversen S, Selmer R, Lochen ML. Rose angina predicts 23-year coronary heart disease mortality in women and men aged 40–49 years. Heart. 2008; 94(4): 4826. DOI: 10.1136/hrt.2007.115931
  23. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 120422. DOI: 10.1016/S0140–;6736(20)30925-9
  24. NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027): 151330. DOI: 10.1016/S0140–;6736(16)00618-8
  25. Brewer LC, Svatikova A, Mulvagh SL. The challenges of prevention, diagnosis and treatment of ischemic heart disease in women. Cardiovascular Drugs and Therapy. 2015; 29(4): 35568. DOI: 10.1007/s10557-015-6607-4
  26. Zuchi C, Tritto I, Ambrosio G. Angina pectoris in women: Focus on microvascular disease. International Journal of Cardiology. 2013; 163(2): 13240. DOI: 10.1016/j.ijcard.2012.07.001
  27. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2008; 117(14): 1787801. DOI: 10.1161/CIRCULATIONAHA.107.726562
  28. Jespersen L, Hvelplund A, Abildstrom SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. European Heart Journal. 2012; 33(6): 73444. DOI: 10.1093/eurheartj/ehr331
  29. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: A report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Archives of Internal Medicine. 2009; 169(9): 84350. DOI: 10.1001/archinternmed.2009.50
  30. Johnson BD, Shaw LJ, Buchthal SD, Merz CNB, Kim HW, Scott KN, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2004; 109(24): 29939. DOI: 10.1161/01.CIR.0000130642.79868.B2
  31. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: Results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. European Heart Journal. 2006; 27(12): 140815. DOI: 10.1093/eurheartj/ehl040
  32. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001; 104(22): 274653. DOI: 10.1161/hc4601.099487
  33. Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RD, Wijeratne S, et al. Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka–Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabetic Medicine. 2008; 25(9): 10629. DOI: 10.1111/j.1464-5491.2008.02523.x
  34. Katulanda P, Jayawardena MA, Sheriff MH, Constantine GR, Matthews DR. Prevalence of overweight and obesity in Sri Lankan adults. Obesity Reviews. 2010; 11(11): 7516. DOI: 10.1111/j.1467-789X.2010.00746.x
  35. Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Rezvi Sheriff MH, Matthews DR. The prevalence, predictors and associations of hypertension in Sri Lanka: A cross-sectional population based national survey. Clinical and Experimental Hypertension. 2014; 36(7): 48491. DOI: 10.3109/10641963.2013.863321
  36. Katulanda P, Wickramasinghe K, Mahesh JG, Rathnapala A, Constantine GR, Sheriff R, et al. Prevalence and correlates of tobacco smoking in Sri Lanka. Asia Pacific Journal of Public Health. 2011; 23(6): 8619. DOI: 10.1177/1010539509355599
  37. Fernando HN, Wimaladasa ITP, Sathkoralage AN, Ariyadasa AN, Udeni C, Galgamuwa LS, et al. Socioeconomic factors associated with tobacco smoking among adult males in Sri Lanka. BMC Public Health. 2019; 19(1): 778. DOI: 10.1186/s12889-019-7147-9
  38. Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Global Health. 2019; 7(6): e748e60. DOI: 10.1016/S2214-109X(19)30045-2
  39. P4H Social Health Protection Network. National UHC Dynamics Card Sri Lanka 2020 [28 June 2021]. Available from https://p4h.world/en/national_uhc_dynamics_card_sri-lanka.
  40. Guyer AL. Procurement of medicines in Sri Lanka: A case study. India Health Systems Project, Working Paper #4. Harvard T.H. Chan School of Public Health; 2021.
  41. Senarathna SM, Mannapperuma U, Fernandopulle BM. Medicine prices, availability and affordability in Sri Lanka. Indian Journal of Pharmacology. 2011; 43(1): 603. DOI: 10.4103/0253-7613.75672
  42. Dabare PR, Wanigatunge CA, Beneragama BH. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka. BMC Public Health. 2014; 14: 817. DOI: 10.1186/1471-2458-14-817
  43. Rathish D, Premarathna I, Jayathilake T, Kandegedara C, Punchihewa K, Ananda L, et al. Availability of essential medicines in selected public, primary and secondary health care institutions of a rural Sri Lankan district: a spot survey. BMC Health Services Research. 2017; 17(1): 11. DOI: 10.1186/s12913-016-1969-2
  44. Ahmed W, Muhammad T, Maurya C, Akhtar SN. Prevalence and factors associated with undiagnosed and uncontrolled heart disease: A study based on self-reported chronic heart disease and symptom-based angina pectoris among middle-aged and older Indian adults. PLoS One. 2023; 18(6): e0287455. DOI: 10.1371/journal.pone.0287455
  45. Patel SA, Deepa M, Shivashankar R, Ali MK, Kapoor D, Gupta R, et al. Comparison of multiple obesity indices for cardiovascular disease risk classification in South Asian adults: The CARRS Study. PLoS One. 2017; 12(4): e0174251. DOI: 10.1371/journal.pone.0174251
  46. WHO CVD Risk Chart Working Group. World Health Organization cardiovascular disease risk charts: Revised models to estimate risk in 21 global regions. Lancet Global Health. 2019; 7(10): e1332e45. DOI: 10.1016/S2214-109X(19)30318-3
  47. Wijemunige N, Rannan-Eliya RP, van Baal P, O’Donnell O. Optimizing cardiovascular disease risk screening in a low-resource setting: cost-effectiveness of program modifications in Sri Lanka modelled with nationally representative survey data. BMC Public Health. 2023; 23(1): 1792. DOI: 10.1186/s12889-023-16640-5
DOI: https://doi.org/10.5334/gh.1330 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jul 11, 2023
Accepted on: May 18, 2024
Published on: Jun 3, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Nilmini Wijemunige, Ravindra P. Rannan-Eliya, H. M. M. Herath, Owen O’Donnell, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.